跳至主要内容
临床试验/JPRN-UMIN000046674
JPRN-UMIN000046674已完成未知

The effects of ingestion of Panax genus plants, extracts, or ginsenosides intake on muscle damage- A systematic review with Meta-analysis. - A systematic review of Panax genus plants or ginsenosides.

Maruzen Pharmaceuticals Co., LTD.0 个研究点目标入组 201 人开始时间: 2022年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
201

研究概览

简要总结

Seven studies met the inclusion criteria. The number of participants was 201, with 105 in the ingestion-Panax genus plants(PGPs) group and 104 in the controlgroup, because including crossover-design trials. Ingestion of PGPs group significantly suppresses the elevated serum creatin kinase(CK) 72 hours after exercise (SMD, 0.58; 95% CI, 0.22-0.95) but with a high I2 value (I2=91%), and not 60 min or 24 hours.

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Literature which does not meet key inclusion criteria will be excluded. Participants who are planning or currently pregnant or breastfeeding, and children (persons under 18 years), will be excluded from this study. If participants have conditions such as any acute or chronic disease which impact their physical exercise ability or their serum creatine kinase: central nervous system, muscular, cardiovascular, pulmonary, endocrine system, gastrointestinal system, and other organ dysfunction, or cancer, they will be excluded. The studies will be excluded from using special dosage form food like foods to avoid digestion or absorption by the gastrointestinal system as intervention foods. For the control group, no intervention is excluded. Literature not written in English or Japanese will be excluded due to inability to verify and perform data extraction.

研究者

相似试验